Svea Grieb

What's Beyond the Bioprocess Automation Starting Line?

The Internet of Things and robotics are already the working standard in fast-adapting industries. Now, these technologies are (conservatively) making inroads into the biopharma industry. Here, we consider what comes next – and assess whether the benefits outweigh the risks.